$24,901
National Institutes of Health
- PIID
- 75N98026F00002
- PSC
- 6505 - DRUGS AND BIOLOGICALS
NAICS 325413
Explore obligations, trends, recent awards, and incumbent contractors for NAICS 325413.
NAICS 325413 covers manufacturing in-vitro diagnostic reagents, kits, controls, and related assay components, including production, formulation, assembly, factory testing, packaging, labeling, and quality records for clinical and point-of-care diagnostic use.
Federal opportunities under 325413 typically involve procuring manufactured IVD materials with validated lot release, documented quality control and batch records, stability and performance testing support, packaging and labeling compliance, and supply continuity for clinical and laboratory testing programs.
FY2021
$591.9M · 726 awards
FY2022
$5.2B · 2,006 awards
FY2023
$1.9B · 1,975 awards
FY2024
$208.5M · 1,764 awards
FY2025
$174.2M · 1,692 awards
FY2026
$122.1M · 779 awards
$24,901
National Institutes of Health
$33,607
Department of Veterans Affairs
$191,530
Department of Veterans Affairs
$0
Department of Veterans Affairs
$165,286
Department of Veterans Affairs
$52,224
Department of Veterans Affairs
$90,847
Food and Drug Administration
$21,300
Department of Veterans Affairs
Now that you know about NAICS 325413 - In-Vitro Diagnostic Substance Manufacturing, let Sweetspot help you find and win relevant government contracts with AI-powered tools.